Vitamin China E-News 2010 (12 issues per year)
Vitamins China E-News provides you with real-time intelligence on China’s vitamins market.
It is a monthly published newsletter, which can be downloaded in PDF format. The subscription period is yearly, grants the subscriber 12 issues in total.
China is the world’s largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China’s tougher stance on environmental protection is also having an effect.
Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:
HEADLINE
On 13 Oct., the Guidelines for Anti-monopoly in the Field of APIs (Consultation Paper) was publicized by the State Administration for Market Regulation to solicit opinions from the publish date until 30 Oct.
Haoyuan Chemexpress noticed on 28 Sept. that its eldecalcitol and intermediate project gained outstanding innovation silver award in the 32nd Shanghai Outstanding Invention Trial and therefore aroused wide concerns.
EIA reports of Brother Pharmaceutical's two projects were publicized in late Sept. The projects are 13,000 t/a VB3, 3,000 t/a fragrance and intermediates project (material changes) and 2,190 t/a fragrance, 8 t/a APIs, 1,500 t/a vitamin and intermediate project.
On 28 Sept., Hongda Biological's food and feed additive project was publicized. The project is newly built for production of food and feed additive VK2 powder/oil.
On 28 Sept., the EIA report of Xiangmin Pharmaceutical's 15 t/a ascorbyl glucoside and 15.625 t/a NMN project gained intended approval from and was published by the Linli Environmental Protection Department of Changde City, Hunan Province.
On 9 Oct., Arawana publicized its IPO prospect on the GEM, disclosing performances of Arawana and its subsidiary, Wilmar Nutrition.
Hanshang Group and its subsidiary, Hanshang Health proposed to acquire Dikang Pharmaceutical's 100% shares with USD132.75 million (RMB900 million). After the acquisition, Dikang Pharmaceutical will become Hanshang Group's wholly-owned subsidiary.
On 13 Oct., Kingdomway announced that its wholly-owned subsidiary, Kingdomway Pharmaceutical has obtained Food Production License for VK2 oil miscible liquid (by fermentation process).
In August, China's vitamin export suffered decreases both in volume and value. And VB1 witnessed rise in export volume (3.86% MoM) yet decline in price (10.54% MoM).
Domestic vitamin witnessed a sluggish market in Oct. Despite positive news for VB3, its price has been falling since June.
It is a monthly published newsletter, which can be downloaded in PDF format. The subscription period is yearly, grants the subscriber 12 issues in total.
China is the world’s largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China’s tougher stance on environmental protection is also having an effect.
Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:
- Breaking news from China and abroad
- The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
- In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
- Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
HEADLINE
On 13 Oct., the Guidelines for Anti-monopoly in the Field of APIs (Consultation Paper) was publicized by the State Administration for Market Regulation to solicit opinions from the publish date until 30 Oct.
Haoyuan Chemexpress noticed on 28 Sept. that its eldecalcitol and intermediate project gained outstanding innovation silver award in the 32nd Shanghai Outstanding Invention Trial and therefore aroused wide concerns.
EIA reports of Brother Pharmaceutical's two projects were publicized in late Sept. The projects are 13,000 t/a VB3, 3,000 t/a fragrance and intermediates project (material changes) and 2,190 t/a fragrance, 8 t/a APIs, 1,500 t/a vitamin and intermediate project.
On 28 Sept., Hongda Biological's food and feed additive project was publicized. The project is newly built for production of food and feed additive VK2 powder/oil.
On 28 Sept., the EIA report of Xiangmin Pharmaceutical's 15 t/a ascorbyl glucoside and 15.625 t/a NMN project gained intended approval from and was published by the Linli Environmental Protection Department of Changde City, Hunan Province.
On 9 Oct., Arawana publicized its IPO prospect on the GEM, disclosing performances of Arawana and its subsidiary, Wilmar Nutrition.
Hanshang Group and its subsidiary, Hanshang Health proposed to acquire Dikang Pharmaceutical's 100% shares with USD132.75 million (RMB900 million). After the acquisition, Dikang Pharmaceutical will become Hanshang Group's wholly-owned subsidiary.
On 13 Oct., Kingdomway announced that its wholly-owned subsidiary, Kingdomway Pharmaceutical has obtained Food Production License for VK2 oil miscible liquid (by fermentation process).
In August, China's vitamin export suffered decreases both in volume and value. And VB1 witnessed rise in export volume (3.86% MoM) yet decline in price (10.54% MoM).
Domestic vitamin witnessed a sluggish market in Oct. Despite positive news for VB3, its price has been falling since June.
Headline
Editor's Note
Governmental Direction
Guidelines for Anti-monopoly in the Field of APIs (Consultation Paper) publicized
Market Dynamics
Eldecalcitol and its intermediate project wins award and arouses concerns
Company Developments
EIA reports of Brother Pharmaceutical's two projects publicized
EIA report of Hongda Biological's food and feed additive project publicized
Xiangmin Pharmaceutical's ascorbyl glucoside and NMN project
Arawana discloses Wilmar Nutrition's performance in its IPO prospect
Hanshang Group to set foot in health field by acquisition of Dikang Pharmaceutical
Kingdomway obtains food production license for VK2
Import and Export Analysis
Imports & exports of selected vitamins in China, Aug. 2020
China's VB1 export volume rises yet its price drops in August
Price Update
Ex-works prices of selected vitamins in China, Oct. 2020
China's VB3 price continues to fall in Oct.
News in Brief
Brother Enterprises predicts net profit growth of 368%–509% in Q1–Q3
Kingdomway predicts net profit growth of 40%–60% in Q1–Q3
Guangji Pharmaceutical predicts net profit cut of 48.18%–59.69% YoY in Q1–Q3
Two major VE enterprises stop receiving orders
NHU Vitamin's trimethyl cyclohexenone and p-chlorophenol project publicized
Baiming Biological's production license for mixed feed additives publicized
Yufeng Corn Circular Economy Industrial Park kick-started
Anxintai Science publishes EIA report of its folic acid upgrading and expansion project
Two vitamin functional products found substandard
China's feed output rises by 7.8% YoY in Q1–Q3
Shengtaier Technology's premix feed (liquid) expansion project publicized
EIA report of Chuwei Pharmaceutical's production project publicized
Editor's Note
Governmental Direction
Guidelines for Anti-monopoly in the Field of APIs (Consultation Paper) publicized
Market Dynamics
Eldecalcitol and its intermediate project wins award and arouses concerns
Company Developments
EIA reports of Brother Pharmaceutical's two projects publicized
EIA report of Hongda Biological's food and feed additive project publicized
Xiangmin Pharmaceutical's ascorbyl glucoside and NMN project
Arawana discloses Wilmar Nutrition's performance in its IPO prospect
Hanshang Group to set foot in health field by acquisition of Dikang Pharmaceutical
Kingdomway obtains food production license for VK2
Import and Export Analysis
Imports & exports of selected vitamins in China, Aug. 2020
China's VB1 export volume rises yet its price drops in August
Price Update
Ex-works prices of selected vitamins in China, Oct. 2020
China's VB3 price continues to fall in Oct.
News in Brief
Brother Enterprises predicts net profit growth of 368%–509% in Q1–Q3
Kingdomway predicts net profit growth of 40%–60% in Q1–Q3
Guangji Pharmaceutical predicts net profit cut of 48.18%–59.69% YoY in Q1–Q3
Two major VE enterprises stop receiving orders
NHU Vitamin's trimethyl cyclohexenone and p-chlorophenol project publicized
Baiming Biological's production license for mixed feed additives publicized
Yufeng Corn Circular Economy Industrial Park kick-started
Anxintai Science publishes EIA report of its folic acid upgrading and expansion project
Two vitamin functional products found substandard
China's feed output rises by 7.8% YoY in Q1–Q3
Shengtaier Technology's premix feed (liquid) expansion project publicized
EIA report of Chuwei Pharmaceutical's production project publicized
